Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016 - GlobalData

Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016

Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016 - GlobalData
Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016
Published Sep 30, 2016
322 pages — Published Sep 30, 2016
Price US$ 2,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

GlobalData's clinical trial report, Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016' provides an overview of Post Menopausal Osteoporosis clinical trials scenario. This report provides top line data relating to the clinical trials on Post Menopausal Osteoporosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

  
Source:
Document ID
GDHC3794CTIDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Report Guidance51
Clinical Trials by Region68
  Clinical Trials and Average Enrollment by Country72
    Top Five Countries Contributing to Clinical Trials in Asia-Pacific91
    Top Five Countries Contributing to Clinical Trials in Europe101
    Top Countries Contributing to Clinical Trials in North America111
    Top Countries Contributing to Clinical Trials in Middle East and Africa121
    Top Five Countries Contributing to Clinical Trials in Central and South America131
Clinical Trials by G7 Countries: Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials141
Clinical Trials by Phase in G7 Countries151
Clinical Trials in G7 Countries by Trial Status161
Clinical Trials by E7 Countries: Proportion of Post Menopausal Osteoporosis to Metabolic Disorders Clinical Trials171
Clinical Trials by Phase in E7 Countries181
Clinical Trials in E7 Countries by Trial Status191
Clinical Trials by Phase202
  In Progress Trials by Phase211
Clinical Trials by Trial Status221
Clinical Trials by End Point Status231
Subjects Recruited Over a Period of Time241
Clinical Trials by Sponsor Type251
Prominent Sponsors263
  Top Companies Participating in Post Menopausal Osteoporosis Therapeutics Clinical Trials272
Prominent Drugs291
Latest Clinical Trials News on Post Menopausal Osteoporosis305
  Sep 18, 2016: Results From Phase 3 FRAME Study Of Romosozumab Showed Significant Reductions In Both New Vertebral And Clinical Fractures In Postmenopausal Women With Osteoporosis301
  Sep 18, 2016: Radius Announces Publication of Additional Positive Results from the Phase 3 ACTIVE Trial of Abaloparatide-SC in JBMR311
  Sep 14, 2016: Amgen to present romosozumab at Investor Call321
  Sep 07, 2016: UCB to present results from Phase 3 FRAME Study at the American Society for Bone and Mineral Research Annual Meeting321
  Aug 16, 2016: JAMA Publishes Positive Phase 3 Data for Abaloparatide in Postmenopausal Women With Osteoporosis331
  Jul 20, 2016: Radius Health Announces Multiple Presentations at the American Society for Bone and Mineral Research 2016 Annual Meeting September 16-19, 2016341
Clinical Trial Profile Snapshots35284
Appendix3193
  Abbreviations3191
  Definitions3191
  Research Methodology3201
  Secondary Research3201
  About GlobalData3211
  Contact Us3211
  Disclaimer3211
Source3221

Table Of Contents

GlobalData—GlobalData uses proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries.

About the Author


Cite this Report

  
MLA:
GlobalData. "Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016" Sep 30, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData/Post-Menopausal-Osteoporosis-Global-Clinical-Trials-Review-H2-2016-2085-24142>
  
APA:
GlobalData. (2016). Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016 Sep 30, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData/Post-Menopausal-Osteoporosis-Global-Clinical-Trials-Review-H2-2016-2085-24142>
  
US$ 2,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.